Colorectal cancer prognosis: is it all mutation, mutation, mutation? by Hassan, A, Paraskeva, C

TGF-ß1 signalling, connecting aberrant inflammation and colorectal tumorigenesis by Paterson, I.C., Skeen, V.R., Paraskeva, C., Williams, A.C.

Get full text

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has... by Varey, A, Rennel, E, Qiu, Y, Bevan, H, Perrin, R, Raffy, S, Dixon, A, Paraskeva, C, Zaccheo, O, Hassan, A, Harper, S, Bates, DO